Urinary 8-oxo-7, 8-dihydro-2′-deoxyguanosine (8-oxo-dG), a reliable oxidative stress marker in hypertension

Free Radical Research

Volumn 41, Issue 5, 2007, Pages 546-554

  Espinosa, Olga ^a   Jiménez Almazán, Jorge ^a   Chaves, Felipe J ^a   Tormos, M Carmen ^a   Clapes, Sonia ^b   Iradi, Antonio ^c   Salvador, Amparo ^d   Fandos, Marta ^d   Redón, Josep ^a   Sáez, Guillermo T ^a,d  

^a UNIVERSITY OF VALENCIA   (Spain)

^b INSTITUTO SUPERIOR DE CIENCIAS MÉDICAS DE LA HABANA   (Cuba)

^c UNIVERSITY OF VALENCIA   (Spain)

^d HOSPITAL GENERAL UNIVERSITARIO DE VALENCIA   (Spain)

Author keywords

8 dihydro 2 deoxyguanosine (8 oxo dG); 8 oxo 7; DNA damage; Hypertension; Oxidative stress marker; Urine

Indexed keywords

8 HYDROXYDEOXYGUANOSINE; ANTIHYPERTENSIVE AGENT; ATENOLOL; CELL NUCLEUS DNA; GLUTATHIONE; GLUTATHIONE DISULFIDE; MITOCHONDRIAL DNA;

ADULT; ARTICLE; BLOOD PRESSURE MEASUREMENT; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE MARKER; DNA DETERMINATION; FEMALE; HUMAN; HUMAN CELL; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MONONUCLEAR CELL; OXIDATIVE STRESS; PATIENT MONITORING; PROTEIN EXPRESSION; PROTEIN ISOLATION; PROTEIN URINE LEVEL; RELIABILITY; URINARY EXCRETION;

ADULT; BIOLOGICAL MARKERS; CELL NUCLEUS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DEOXYGUANOSINE; DNA, MITOCHONDRIAL; FEMALE; GLUTATHIONE; GLUTATHIONE DISULFIDE; HUMANS; HYPERTENSION; MALE; OXIDATIVE STRESS;

EID: 34047109711     PISSN: 10715762     EISSN: 10292470     Source Type: Journal    
DOI: 10.1080/10715760601164050     Document Type: Article

References (41)

1. Halliwell, B. and Gutteridge, JMC (1999) Free radicals in biology and medicine, Oxford University Press, Oxford, UK
2. Romero, JC and Reckelhoff, JF (1999) Role of angiotensin and oxidative stress in essential hypertension. Hypertension, 34, pp. 943-949.
3. Griffiths, G. (2002) Biomarkers. Mol Aspects Med, 23, pp. 101-208.
4. Vassalle, C., Botto, N., Andreassi, G., Berti, S. and Beiagini, A. (2003) Evidence for enhanced 8-isoprostane plasma levels, as an index of oxidative stress in vivo, in patients with coronary artery disease. Coron Artery Dis, 14, pp. 213-218.
5. Minuz, P., Andrioli, G., Degan, D., Gaino, S., Ortalani, R., Tommasolim, R., Zuliani, V., Lechi, A. and Lechi, C. (1998) The F2-isoprostane 8-epiprotanglandin F2alpha increases platelet adhesion and reduces the antiadhesive and antiaggregatory effects of NO. Arterioscler Thromb Vasc Biol, 18, pp. 1248-1256.
6. Chen, KC, Achill, SS, Kasai, DS, Nishimura, S. and Loeb, LA (1992) 8-hydroxyguanine, an abundant form of oxidative DNA damage, causes G-T to A-C susbstitutions. J Biol Chem, 267, pp. 166-172.
7. Gedik, CM and Collins, A. (2005) Establishing the background level of base oxidation in human lymphocyte DNA: Results of an interlaboratory validation study. FASEB J, 19:1, pp. 82-84.
8. Nakabeppu, Y., Tsuchimoto, D., Ichinoe, A., Ohno, M., Ide, Y., Hirano, S., Yoshimura, D., Tominaga, Y., Furuichi, M. and Sakumi, K. (2004) Biological significance of the defense mechanisms against oxidative damage in nucleic acids caused by reactive oxygen species. From mitochondria to nuclei. Ann NY Acad Sci, 1011, pp. 101-111.
9. Cooke, MS, Evans, MD, Herbert, KE and Lunec, J. (2000) Urinary 8-oxo-2′-deoxyguanosine- source, significance and supplements. Free Radic Res, 32, pp. 381-397.
10. Oliva, MR, Ripoll, F., Muñiz, P., Iradi, A., Trullenque, R., Valls, V., Drehmer, E. and Sáez, GT (1997) Genetic alterations and oxidative metabolism in sporadic colorectal tumors from a Spanish community. Mol Carcinog, 18, pp. 232-243.
11. Tormos, C., Chaves, FJ, García, MJ, Garrido, F., Jover, R., O'Connor, JE, Iradi, A., Oltra, A., Oliva, MR and Sáez, GT (2004) Role of glutathione in the induction of apoptosis and c-fos and c-jun mRNAs by oxidative stress in tumor cells. Cancer Lett, 208, pp. 103-113.
12. Hamilton, ML, Guo, Z., Fuller, CD, Van Remmen, H., Ward, WF, Austad, SN, Troyer, DA, Thompson, I. and Richardson, A. (2001) A reliable assessment of 8-oxo-2-deoxyguanosine levels in nuclear and mitochondrial DNA using the sodium iodide method to isolate DNA. Nucleic Acids Res, 29, pp. 2117-2126.
13. Topp, H., Armbrust, S., Lengger, C., Schoch, G., Davies, J., Stichler, W., Manz, F. and Fusch, C. (2002) Renal excretion of 8-oxo-7,8-dihydro-2′-deoxyguanosine, degradation rates of RNA and metabolic rate in humans. Arch Biochem Biophys, 403, pp. 31-37.
14. Chobanian, AV, Bakris, GL, Black, HR, Cushman, WC, Green, LA, Izzo Jr., JL, Jones, DW, Materson, BJ, Oparil, S., Wright Jr, JT and Roccella, EJ (2003) The seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: The JNC 7 report. JAMA, 289, pp. 2560-2572.
15. Petrie, JC, O'Brien, ET, Littler, WA and De Swiet, M. (1986) Recommendations on blood pressure measurement. Br Med J, 293, pp. 611-615.
16. Redon, J., Miralles, A., Liao, Y., Lozano, JV, Pascual, JM and Cooper, RS (1994) Circadian variability and microalbuminuria in essential hypertension. J Hypertens, 12, pp. 947-954.
17. Boyum, A. (1968) Isolation of mononuclear cells and granulocytes from human blood. Scan J Clin Lab Invest, 21, pp. 77-89.
18. Muñiz, P., Valls, V., Perez-Broseta, C., Iradi, A., Climent, JV, Oliva, MR and Sáez, GT (1995) The role of 8-hydroxy-2′-deoxyguanosine in rifamycin-induced DNA damage. Free Radic Biol Med, 18, pp. 747-755.
19. Asensi, MD, Sastre, J., Pallardó, FV, de la Asunción, J García, Estrela, JM and Viña, J. (1994) A high-performance liquid chromatography method for measurement of oxidized glutathione in biological samples. Anal Biochem, 217, pp. 323-328.
20. Frenkel, K., Zong, Z., Wei, H., Karkiszka, J., Patel, U., Rashid, K., Georgescu, M. and Solomon, JJ (1991) Quantitative high performance liquid chromatography analysis of DNA oxidized in vitro and in vivo. Anal Biochem, 196, pp. 126-136.
21. Latorre, A., Moya, A. and Ayala, FJ (1986) Evolution of mitochondrial DNA in Drosophila subobscura. Proc Natl Acad Sci USA, 83, pp. 8649-8653.
22. Wei, H. and Frenkel, K. (1992) Suppression of tumor promoter-induced oxidative events and DNA damage in vivo by sarcophytol A: A possible mechanism of antipromotion. Cancer Res, 52, pp. 2298-2303.
23. Brown, RK, McBurney, A., Lunec, J. and Kelly, FJ (1995) Oxidative damage to DNA in patients with cystic fibrosis. Free Radic Biol Med, 18, pp. 801-806.
24. Raij, L. (1998) Nitric oxide in hypertension: Relationship with renal injury and left ventricular hypertrophy. Hypertension, pp. 189-193.
25. Nakazono, K., Watanabe, N., Matsuno, K., Sasaki, J. and Inoue, M. (1991) Does superoxide underlie the pathogenesis of hypertension?. Proc Natl Acad Sci USA, 88, pp. 10045-10048.
26. Wallwork, CJ, Parks, DA and Schmid-Schonbein, GW (2003) Xanthine oxidase activity in the dexametasone-induced hypertensive rat. Microvasc Res, 66:1, pp. 30-37.
27. Cifuentes, ME and Pagano, PJ (2006) Targeting reactive oxygen species in hypertension. Curr Opin Nephrol Hypertens, 15:2, pp. 179-186.
28. Redon, J., Oliva, MR, Tormos, C., Giner, V., Chaves, J., Iradi, A. and Saez, GT (2003) Antioxidant activities and oxidative stress byproducts in human hypertension. Hypertension, 41, pp. 1096-1101.
29. Blankenberg, S., Rupprecht, HJ, Bickel, Ch, Torzewski, M., Hafner, G., Tiret, L., Smieja, M., Cambien, F., Meyer, J. and Lackner, KJ (2003) Glutathione peroxidase 1 activity and cardiovascular events in patients with coronary artery disease. N Engl J Med, 349, pp. 1605-1613.
30. Lenton, KJ, Therrialut, H., Fulop, H., Payette, H. and Wagner, JR (1999) Glutathione and ascorbate are negatively correlated with oxidative DNA damage in human lymphocytes. Carcinogenesis, 4, pp. 607-613.
31. Giner, V., Tormos, C., Chaves, FJ, Saez, G. and Redon, J. (2004) Microalbuminuria and oxidative stress in essential hypertension. J Intern Med, 255, pp. 588-594.
32. Saez, GT, Tormos, C., Giner, V., Chaves, FJ, Lozano, JV, Iradi, A. and Redon, J. (2004) Factors related to the impact of antihypertensive treatment in antioxidant activities and oxidative stress byproducts in human hypertension. Am J Hypertens, 17, pp. 809-816.
33. Foksinski, M., Gackowski, D., Rozalski, R. and Olinski, R. (2003) Cellular level of 8-oxo-2′-deoxyguanosine in DNA does not correlate with urinary excretion of the modified base/nucleoside. Acta Biochim Pol, 50, pp. 549-553.
34. Lunec, J., Holloway, KA, Cooke, MS, Faux, S., Griffiths, HR and Evans, MD (2002) Urinary 8-oxo2′-deoxyguanosine: Redox regulation of DNA repair in vivo?. Free Radic Biol Med, 33, pp. 875-885.
35. Gackowski, D., Rozalski, R., Roszkowski, K., Jawien, A., Foksinski, M. and Olinski, R. (2001) 8-oxo-7,8-dihydroguanine and 8-oxo-7,8-dihydro-2′-deoxyguanosine levels in human urine do not depend on diet. Free Radic Res, 35, pp. 825-832.
36. Hayakawa, H., Taketomi, A., Sakimi, K., Kuwano, M. and Sekiguchi, M. (1995) Generation and elimination of 8-oxo-7,8-dihydro-2′-deoxyguanosine 5′-triphosphate, a mutagenic substrate for DNA synthesis, in human cells. Biochemistry, 34, pp. 89-95.
37. Cooke, MS, Evans, MD, Dove, R., Rozallski, R., Gackowski, D., Siomek, A., Lunec, J. and Olinski, R. (2005) DNA repair is responsible for the presence of oxidatively damaged DNA lesions in urine. Mutat Res, 574, pp. 58-66.
38. Cooke, MS, Evans, MD, Burd, RM, Patel, K., Barmad, A., Lunec, J. and Hutchinson, PE (2001) Induction and excretion of ultraviolet-induced 8-oxo-2′-deoxyguanosine and thymine dimmers in vivo: Implications for PUVA. J Invest Dermatol, 116, pp. 281-285.
39. Loft, S., Pousen, HE, Vistisen, K. and Knudsen, LE (1999) Increased urinary excretion of 8-oxo-2′-deoxyguanosine, a biomarker of oxidative DNA damage, in urban bus drivers. Mutat Res, 441, pp. 11-19.
40. Lenger, C., Schöch, G. and Topp, H. (2000) A high-performance liquid chromatographic method for the determination of 8-oxo-7,8-2′-deoxyguanosine in urine from man and rat. Anal Biochem, 287, pp. 65-72.
41. Weiman, A., Belling, D. and Poulsen, H. (2002) Quantification of 8-oxo-guanine and guanine as the nucleobase, nucleoside and deoxynucleoside forms in human urine by high-performance liquid chromatography-electrospray mass spectrometry. Nucleic Acid Res, 30, pp. 4-8.